Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NALICE-TNK in Acute Spontaneous Lobar Intracerebral Hemorrhage
NCT07471256Phase 3Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in intracerebral hemorrhage (ICH), sponsored by Beijing Tiantan Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07471256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07471256.